益盛药业
(002566)
| 流通市值：18.80亿 | | | 总市值：26.84亿 |
| 流通股本：2.32亿 | | | 总股本：3.31亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 115,847,462.79 | 101,981,306.14 | 110,345,172.16 | 71,479,841.19 |
| 交易性金融资产 | 454,041,839.42 | 454,508,208.42 | 468,258,092.47 | 459,671,708.03 |
| 应收票据及应收账款 | 161,985,537.56 | 164,096,520.61 | 157,039,835.88 | 150,627,454.1 |
| 其中：应收票据 | 842,679.46 | 1,089,433.4 | 884,826.2 | 1,092,066.42 |
| 应收账款 | 161,142,858.1 | 163,007,087.21 | 156,155,009.68 | 149,535,387.68 |
| 应收款项融资 | 49,482,512.25 | 57,532,269.05 | 48,404,312.18 | 48,402,514.61 |
| 预付款项 | 5,241,595.37 | 7,310,689.61 | 5,585,608.87 | 1,578,217.09 |
| 其他应收款合计 | 20,425,667.65 | 17,833,164.48 | 19,133,680.22 | 15,046,882.82 |
| 存货 | 1,605,333,846.06 | 1,613,133,248.59 | 1,615,542,471.37 | 1,626,488,729.46 |
| 其他流动资产 | 2,283,845.35 | 2,548,404.29 | 2,262,131.59 | 2,484,964.33 |
| 流动资产合计 | 2,414,642,306.45 | 2,418,943,811.19 | 2,426,571,304.74 | 2,375,780,311.63 |
| 非流动资产: | | | | |
| 长期股权投资 | 36,700 | - | - | - |
| 固定资产 | 412,761,356.68 | 421,885,930.21 | 429,972,955.74 | 437,935,245.15 |
| 使用权资产 | 12,834,919.92 | 13,940,203.5 | 11,318,688.19 | 12,401,656.85 |
| 无形资产 | 109,454,460.59 | 110,006,043.28 | 110,689,706.95 | 111,348,014.44 |
| 商誉 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 | 1,905,827.33 |
| 长期待摊费用 | 1,665,134.91 | 1,819,822.85 | 1,863,286.99 | 2,153,090.27 |
| 递延所得税资产 | 14,175,777.07 | 13,744,651.43 | 13,159,642.67 | 13,147,314.12 |
| 其他非流动资产 | 16,142,627.89 | 15,860,086.51 | 16,945,327.12 | 15,982,925.83 |
| 非流动资产合计 | 568,976,804.39 | 579,162,565.11 | 585,855,434.99 | 594,874,073.99 |
| 资产总计 | 2,983,619,110.84 | 2,998,106,376.3 | 3,012,426,739.73 | 2,970,654,385.62 |
| 流动负债: | | | | |
| 短期借款 | 348,231,111.1 | 348,231,869.43 | 345,018,874.14 | 290,283,555.56 |
| 应付票据及应付账款 | 10,663,685.39 | 15,160,917.96 | 13,598,996.38 | 13,001,831.67 |
| 应付账款 | 10,663,685.39 | 15,160,917.96 | 13,598,996.38 | 13,001,831.67 |
| 合同负债 | 8,521,712.95 | 8,433,601.1 | 5,384,929.13 | 5,492,542.94 |
| 应付职工薪酬 | 5,242,327.09 | 8,515,694.16 | 7,991,762.62 | 6,846,279.33 |
| 应交税费 | 11,856,622.88 | 12,806,943.05 | 9,609,169.97 | 8,559,848.74 |
| 其他应付款合计 | 25,403,127.71 | 32,875,214.51 | 28,575,229.87 | 37,722,466.23 |
| 一年内到期的非流动负债 | 4,024,203.09 | 3,601,898.24 | 3,816,896.7 | 3,398,981.11 |
| 其他流动负债 | 1,092,642.53 | 1,079,156.07 | 676,040.33 | 696,712.19 |
| 流动负债合计 | 415,035,432.74 | 430,705,294.52 | 414,671,899.14 | 366,002,217.77 |
| 非流动负债: | | | | |
| 长期借款 | 129,700,000 | 129,880,000 | 134,700,000 | 149,700,000 |
| 租赁负债 | 5,114,258.56 | 6,200,478.96 | 3,617,567.46 | 6,205,673.58 |
| 递延收益 | 106,985,855.62 | 109,064,086.81 | 111,381,726.59 | 112,541,655.91 |
| 递延所得税负债 | 2,025,537.31 | 2,091,256.67 | 2,584,514.52 | 2,770,442.76 |
| 非流动负债合计 | 243,825,651.49 | 247,235,822.44 | 252,283,808.57 | 271,217,772.25 |
| 负债合计 | 658,861,084.23 | 677,941,116.96 | 666,955,707.71 | 637,219,990.02 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,951,600 | 330,951,600 | 330,951,600 | 330,951,600 |
| 资本公积 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 | 834,689,338.39 |
| 盈余公积 | 145,392,996.97 | 145,392,996.97 | 145,392,996.97 | 145,392,996.97 |
| 未分配利润 | 915,605,877.34 | 910,241,314.88 | 936,434,288.86 | 924,572,718.84 |
| 归属于母公司股东权益合计 | 2,226,639,812.7 | 2,221,275,250.24 | 2,247,468,224.22 | 2,235,606,654.2 |
| 少数股东权益 | 98,118,213.91 | 98,890,009.1 | 98,002,807.8 | 97,827,741.4 |
| 股东权益合计 | 2,324,758,026.61 | 2,320,165,259.34 | 2,345,471,032.02 | 2,333,434,395.6 |
| 负债和股东权益合计 | 2,983,619,110.84 | 2,998,106,376.3 | 3,012,426,739.73 | 2,970,654,385.62 |
| 公告日期 | 2025-10-27 | 2025-08-23 | 2025-04-24 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |